OPULUS
Welcome Guest (Log in, Subscribe
 What's New | Home | About Us | Contact Us | Help Center | Publications | Site Map | Links | Subscription 


Last update: 2006. 03. 08.
 Regulatory Basis  Forum Issues  Intelligence Services  Web Applications  21 CFR Part 11 Compliant Products 

Search: 
Intelligence Services
Endotoxin
OOS
21 CFR Part 11
Dissolution
Competency Training
Blend Uniformity
Validation
Patent databases


Adobe Acrobat Reader
Where are you now? Intelligence Services > Endotoxin > Related Warning Letters

LAL-Endotoxin Related Warning Letters

These files are in Adobe PDF format.
Click on the "Get Acrobat Reader" icon on the left of the page to
download a free copy of the Acrobat Reader.

PDF PDF file (323 KB)
Cleveland Clinic Foundation, 2002-03-26
"You did not perform the protocol-required tests for endotoxin and mycoplasma prior to the infusion of the investigational xxx for all study subjects."

PDF PDF file (359 KB)
Dayton Water Systems, 2002-03-14
"The cause was that the LAL test results were not within specifications....There was no documentation that a failure investigation was performed and no corrective action was implemented for the LAL test failures."

PDF PDF file (420 KB)
Tyco International Ltd., 2002-03-08
"Radionics' Pyrogen Procedure QS3-09-0065, Rev. A does not specify that all implanted device configurations be tested for pyrogenicity."

PDF PDF file (518 KB)
Medical Device Services, Inc., 2001-12-13
"The validation testing for sterilization process, LAL bioburden, and residuals will be completed by October 10, 2001. This response is inadequate in that calibration by itself cannot provide assurance that the requirements of a sterilized product can be consistently fulfilled."

PDF PDF file (256 KB)
Ferro Corporation, 2001-07-06
"Investigations were not completed for several incidents of Purified Water not meeting specifications for microbial contamination and endotoxin levels during the Performance Qualification testing."

PDF PDF file (257 KB)
Eli Lilly and Company, 2001-03-02